十余载磨剑 破壁向全球

Core Viewpoint - Harbin Sizhirui Intelligent Medical Equipment Co., Ltd. has achieved a significant milestone by obtaining the CB certificate for its independently developed Kando robot endoscopic surgical system, marking it as the first domestic laparoscopic surgical robot system in China to receive this certification, which is recognized by over 50 member countries of the International Electrotechnical Commission [1][5]. Group 1: Product Development and Innovation - The Kando robot SR1000 received the Class III medical device registration certificate in June 2022, officially entering clinical use, and offers comparable clinical outcomes to foreign brands while reducing costs to half of imported competitors [3]. - The company has developed over 500 patents and has been recognized as a national intellectual property advantage enterprise and a "little giant" enterprise, showcasing its commitment to innovation and quality control [4]. - The Kando robot has won multiple international design awards, including the German Red Dot Award and the American IDEA Award, reflecting its innovative capabilities [4]. Group 2: International Recognition and Market Expansion - The CB certificate signifies that the Kando robot SR2000 meets international safety standards, validating its technology against global competitors and enhancing confidence in Chinese high-end medical equipment [5]. - The company has trained approximately 10,000 foreign clinical engineers from countries such as Malaysia, Greece, Mexico, and Turkey, indicating a strong global outreach [5]. - The Kando robot has been installed in nearly 50 countries and regions, with over 100 units installed and more than 15,000 surgeries completed, demonstrating significant market penetration [6]. Group 3: Future Outlook - The company aims to continue advancing its surgical robots in system intelligence, clinical adaptability, and global market access, striving to provide safer, more precise, and accessible intelligent surgical solutions for doctors and patients worldwide [6].